INO-4800

Status
Phase 1
Condition
COVID-19
Intervention Type
Intradermal (ID) Injection
Funder Type
Industry

Drug Details

INO-4800 is a DNA vaccine candidate designed to prevent COVID-19 infection.

Study Purpose

This is an open-label trial to evaluate the safety, tolerability and immunological profile of INO-4800 administered by intradermal (ID) injection followed by electroporation (EP) using CELLECTRA® 2000 device in healthy adult volunteers.

Find a Clinical Trial

 

footer_txt_bblBook a PFF Ambassador for your event.   Call 844.TalkPFF >